Envarsus xr and Abortion induced - a phase IV clinical study of FDA data
Summary:
No or few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or few reports are found.
What is Envarsus Xr?
Envarsus xr has active ingredients of tacrolimus. Currently, eHealthMe is studying from 3,531 Envarsus xr users.
What is Abortion Induced?
Abortion induced (medically referred abortion) is found to be associated with 1,149 drugs and 787 conditions by eHealthMe. Currently, we are studying 14,814 people who have Abortion induced.
Do you take Envarsus xr and have Abortion induced?
Check whether Abortion induced is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Envarsus xr side effects by duration, gender and age:
- Envarsus xr side effects (3,531 reports)
Abortion induced treatments and more:
- Abortion induced (14,814 reports)
All the drugs that are associated with Abortion induced:
All the conditions that are associated with Abortion induced:
How the study uses the data?
The study uses data from the FDA. It is based on tacrolimus (the active ingredients of Envarsus xr) and Envarsus xr (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Prezista and Pulmonary Tuberculosis - 6 seconds ago
- Nucynta and General Physical Health Deterioration - 7 seconds ago
- Tabrecta and Swallowing Difficulty - 12 seconds ago
- Lupron Depot and Itching - 13 seconds ago
- Tysabri and Trasylol drug interaction - 14 seconds ago
- Xeloda and Eosinophil Count Decreased - 14 seconds ago
- Amiodarone Hydrochloride and Loteprednol Etabonate drug interaction - 16 seconds ago
- Alphagan P and Muscle Spasms - 20 seconds ago
- Cozaar and Tasigna drug interaction - 23 seconds ago
- Zetia and Abdominal Discomfort - 30 seconds ago